We are glad to inform the successful development of complex Levothyroxine oral drops formulation for Europe.
Please, note that Intas B2B has full range of pharmaceutical forms of Levothyroxine in the portfolio including tablets with the dossier approved and soft-gel capsules, unit dose and multi dose oral solution to be completed during this year.
Feel free to reach out to our BD&L team for more licensing opportunities and supply partnerships.
